Bausch Health Companies Inc.

CIK 885590 · last filed 2022-06-02

Bausch Health Companies Inc. is a corporate insider who has filed 2 SEC Form 4 insider transactions across 1 company since 2022. The most recent filing shows the insider sold $77.6M of BLCO on Jun 2, 2022. Across all open-market trades the lifetime net is −$674.5M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $5.60B across reported positions. The firm reports its address in Quebec, A8. 59 SEC filings were submitted jointly with John Paulson.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$5.60B

Companies

1

Total Filings

2

Lifetime Open-Market Net

-$674.53M

Filer Profile

Reported Address

2150 ST. ELZEAR BLVD. WEST
LAVAL
QUEBEC, A8 H7L 4A8

Phone

(514) 744-6792

State of Incorporation

Formerly Known As

Valeant Pharmaceuticals International, Inc. (2010–2018)

BIOVAIL Corp (2005–2010)

BIOVAIL CORP INTERNATIONAL (2001–2010)

BIOVAIL CORPORATION INTERNATIONAL (1996–2001)

Related Filers

John Paulson — 59 joint filings, latest 2026-07-02

Pershing Square Capital Management, L.P. — 56 joint filings, latest 2017-05-03

AMY B WECHSLER — 55 joint filings, latest 2026-07-02

VA Partners I, LLC — 54 joint filings, latest 2022-05-13

Norma Ann Provencio — 45 joint filings, latest 2016-05-04

THOMAS APPIO — 44 joint filings, latest 2026-03-03

RICHARD U DE SCHUTTER — 44 joint filings, latest 2023-04-04

RUSSEL C ROBERTSON — 44 joint filings, latest 2024-04-01

Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
BLCO	10%+ Owner	310,449,643	$18.04	$5.60B	-$674.53M	2	2022-06-02

Recent Filings

2 filings

Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.

Filed	Symbol	Action	Net Shares	Net $	Link
2022-06-02	BLCO	Sell (S)	−4,550,357	-$77.61M	EDGAR
2022-05-12	BLCO	Sell (S)	−35,000,000	-$596.92M	EDGAR

Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.